SLU-PP-322 Research Guide: Exercise Mimetic, ERR Agonism & Metabolic Studies

SLU-PP-322 is a synthetic small-molecule compound that has attracted significant attention in metabolic and exercise biology research for its ability to activate estrogen-related receptors (ERRs) — the same nuclear receptor pathway engaged during physical exercise. In preclinical models, SLU-PP-322 research has explored how ERR agonism can replicate aspects of aerobic exercise at the molecular level, earning it the informal designation of an exercise mimetic. As researchers look for precise tools to study metabolic adaptation, mitochondrial function, and skeletal muscle physiology, SLU-PP-322 has emerged as a compelling compound worthy of in-depth investigation.

This guide provides a structured overview of what current science knows about SLU-PP-322, covering its receptor targets, observed effects in preclinical research, comparisons to related compounds, and how it fits within the broader landscape of metabolic peptide research.

Research-only notice: This content is provided for educational discussion and laboratory research purposes only. No medical claims are made or implied. SLU-PP-322 is not approved for human use and is intended exclusively for qualified researchers in controlled laboratory settings.

🎫 First order? Save 25% with code WELCOMEHOME at checkout

Research compounds discussed in this guide

SLU — PP — 332 — 5MG

SLU-PP-332 - 5MG — Research-Grade Reference Material SLU-PP-332 - 5MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…

$75.00 ($56.25 With Your 1st Order)

View Research Data

For research use only · 3rd-party tested · Free 2-5 day US shipping

Frequently Asked Questions

What is SLU-PP-322?

SLU-PP-322 is a synthetic small-molecule compound developed as a pan-ERR (estrogen-related receptor) agonist. Research suggests it activates ERRα, ERRβ, and ERRγ — nuclear receptors involved in mitochondrial biogenesis, fatty acid oxidation, and exercise-induced metabolic adaptations. It has been studied in preclinical models as a potential exercise mimetic.

What receptors does SLU-PP-322 target?

SLU-PP-322 has been shown in research to act as an agonist at all three estrogen-related receptors: ERRα, ERRβ, and ERRγ. These orphan nuclear receptors regulate gene expression pathways associated with oxidative metabolism, mitochondrial function, and energy homeostasis — pathways that are also activated during sustained aerobic exercise.

Why is SLU-PP-322 called an exercise mimetic?

Studies have investigated SLU-PP-322’s ability to activate ERR-driven transcriptional programs that overlap significantly with those triggered by physical exercise. In animal models, researchers observed metabolic shifts consistent with exercise adaptation, including increased fatty acid oxidation and mitochondrial gene expression, without the mechanical stimulus of movement.

What has SLU-PP-322 research shown in animal models?

Preclinical research has explored SLU-PP-322’s effects on skeletal muscle metabolism, cardiac function, body composition, and endurance capacity in rodent models. Studies have reported increased running endurance, shifts in fuel utilization, and upregulation of mitochondrial biogenesis markers. These findings remain in early-stage research and have not been validated in human clinical trials.

Is SLU-PP-322 a peptide?

SLU-PP-322 is technically a small molecule rather than a peptide (it is not composed of amino acid chains). However, it is commonly studied alongside peptide research compounds in the context of metabolic biology and mitochondrial signaling, and is frequently categorized within the research peptide space for laboratory procurement purposes.

How does SLU-PP-322 compare to MOTS-C in metabolic research?

Both SLU-PP-322 and MOTS-C have been studied for their roles in metabolic regulation and mitochondrial function, but they work through distinct mechanisms. MOTS-C is a mitochondrial-derived peptide that activates AMPK pathways, while SLU-PP-322 operates primarily through ERR nuclear receptor agonism. Research may explore these compounds as complementary tools for studying metabolic adaptation from different angles.

What format is SLU-PP-322 available in for research?

For laboratory research, SLU-PP-322 is commonly available in a 5MG lyophilized format. This allows researchers to prepare precise solution concentrations for in vitro or in vivo preclinical studies. Proper reconstitution, storage at appropriate temperatures, and sterile handling are standard requirements for research-grade compounds of this type.

What is the significance of ERR agonism in metabolic research?

Estrogen-related receptors (ERRα, ERRβ, ERRγ) are orphan nuclear receptors with no known endogenous ligand, making synthetic agonists like SLU-PP-322 valuable research tools. ERR activation is associated with regulation of genes involved in oxidative phosphorylation, fatty acid metabolism, and mitochondrial biogenesis — making ERR agonism a focal point in studies of metabolic disease, muscle wasting, and exercise physiology.

The Science Behind SLU-PP-322: ERR Receptor Mechanism

The foundational research interest in SLU-PP-322 centers on its pan-ERR agonist activity. Estrogen-related receptors are a subfamily of nuclear receptors — transcription factors that, when activated, bind to specific DNA sequences and drive gene expression programs. Unlike classical estrogen receptors, ERRs do not respond to estrogen itself; they are considered “orphan” receptors because their endogenous ligands remain poorly characterized.

🎫 First order? Save 25% with code WELCOMEHOME at checkout

Research compounds discussed in this guide

SLU — PP — 332 — 5MG

$75.00 ($56.25 With Your 1st Order)

View Research Data

For research use only · 3rd-party tested · Free 2-5 day US shipping

What researchers have established is that ERRα, ERRβ, and ERRγ each play distinct yet overlapping roles in energy metabolism. ERRα is highly expressed in metabolically active tissues including the heart, skeletal muscle, and brown adipose tissue, where it governs fatty acid oxidation and mitochondrial biogenesis. ERRγ is expressed prominently in cardiac and slow-twitch skeletal muscle, with studies linking its activity to oxidative fiber type programs. ERRβ is less extensively characterized but contributes to similar transcriptional networks in select tissue contexts.

SLU-PP-322 was developed specifically to engage all three subtypes simultaneously — making it a pan-ERR agonist. This simultaneous activation creates a broad transcriptional shift that research models suggest mirrors the molecular signature of sustained aerobic exercise. Published studies indicate upregulation of genes such as ESRRA, PPARGC1A (PGC-1α), and key mitochondrial complex subunits following SLU-PP-322 exposure in cell culture and rodent tissues.

For researchers interested in the full mechanistic breakdown of SLU-PP-322’s ERR pathway activity, a dedicated mechanism overview provides additional depth on the transcriptional cascades involved.

Preclinical Research Findings: What Studies Have Explored

Skeletal Muscle and Endurance Physiology

One of the most widely cited areas of SLU-PP-322 research involves skeletal muscle adaptation. In rodent models, studies have reported measurable increases in running endurance following compound administration. Researchers attribute this to a shift toward oxidative metabolism in skeletal muscle — specifically, increased expression of mitochondrial genes and a phenotypic lean toward slow-oxidative fiber characteristics. This is consistent with the known biology of ERR agonism and the role of PGC-1α co-activation in muscle fiber type plasticity.

The relevance of this research area extends to investigations of conditions involving muscle deconditioning, aging-related sarcopenia models, and scenarios where subjects cannot engage in physical exercise — making a pharmacological analog of exercise adaptation a meaningful research hypothesis.

Cardiac Metabolism

Research has also explored SLU-PP-322’s effects on cardiac tissue, which relies almost exclusively on oxidative metabolism for energy. ERRγ, in particular, has been identified as a key regulator of cardiac metabolic gene expression. Studies investigating SLU-PP-322 in cardiac contexts have examined whether ERR agonism can maintain or improve mitochondrial function in cardiomyocytes under metabolic stress conditions. While findings are preliminary, this area represents an active and growing research interest.

Body Composition and Fat Metabolism

Preclinical models have investigated SLU-PP-322’s influence on body composition, particularly fat mass and adipose tissue metabolism. ERRα plays a significant role in regulating fatty acid oxidation in both muscle and fat tissue. Studies suggest that SLU-PP-322 administration in animal models may increase oxidative fuel utilization, with some models reporting reductions in fat accumulation compared to controls. This positions SLU-PP-322 as an interesting tool within the broader landscape of metabolic research compounds.

For context, other metabolic compounds studied in this space include MOTS-C, which has been extensively studied for its mitochondrial and metabolic signaling properties. Researchers comparing these compounds note that SLU-PP-322 operates through a nuclear receptor mechanism while MOTS-C signals through cytosolic AMPK pathways — offering distinct but potentially complementary research angles.

Neurological and Systemic Research

ERRγ is expressed in neurons and glial cells, and emerging research has begun examining whether ERR agonism via SLU-PP-322 may have relevance to neuronal metabolism and mitochondrial function in central nervous system contexts. This area is nascent compared to the skeletal muscle and cardiac research literature, but it reflects the broader interest in ERR biology across tissue types.

SLU-PP-322 – 5MG for laboratory research →

SLU-PP-322 vs Related Metabolic Research Compounds

Feature	SLU-PP-322	MOTS-C	5-Amino-1MQ
Compound type	Small molecule (ERR agonist)	Mitochondrial peptide	Small molecule (NNMT inhibitor)
Primary target	ERRα, ERRβ, ERRγ (nuclear receptors)	AMPK pathway	NNMT enzyme
Research focus	Exercise mimetic, oxidative metabolism	Metabolic regulation, insulin signaling	Fat cell metabolism, NAD+ precursor flux
Mitochondrial relevance	High (biogenesis, oxidative phosphorylation)	High (mt-ORF derived, AMPK activation)	Moderate (via NAD+ pathway influence)
Skeletal muscle research	Extensive	Moderate	Limited
Body composition models	Yes (fat oxidation focus)	Yes (glucose/lipid metabolism)	Yes (adipocyte metabolism)
Research stage	Preclinical (animal models)	Preclinical + early human data	Preclinical

Choose SLU-PP-322 if…

Your research focuses specifically on ERR nuclear receptor biology and transcriptional regulation of oxidative metabolism
You are investigating exercise adaptation models or conditions of physical deconditioning in animal systems
Your study design involves mitochondrial biogenesis gene expression readouts (PGC-1α, ESRRA, mitochondrial complex genes)
You want to explore skeletal muscle fiber type plasticity mechanisms in preclinical models

Choose MOTS-C if…

Your research targets AMPK-mediated metabolic signaling rather than nuclear receptor transcriptional programs
You are investigating insulin sensitivity models or metabolic syndrome-related biology
Your focus includes the emerging field of mitochondrial-derived peptides as signaling molecules

MOTS-C – 10MG Nasal Spray for metabolic signaling research →

⚡ UNLOCK 25% OFF YOUR FIRST ORDER

Create a free account — get new-customer pricing on every research peptide, plus new research summaries delivered to your inbox.

For research use only. No spam — unsubscribe anytime.

Research Context: Why Exercise Mimetics Matter in Science

The concept of an exercise mimetic — a compound that pharmacologically activates molecular pathways engaged by physical activity — has long been a goal of metabolic biology research. Exercise produces a remarkable array of beneficial adaptations: improved mitochondrial density, enhanced insulin sensitivity, shifts in fuel utilization, reduced inflammation markers, and protective effects in cardiac and skeletal muscle. Identifying the molecular switches responsible for these adaptations is a central question in exercise physiology and translational research.

SLU-PP-322 represents one approach to studying this question: if ERRs are necessary and sufficient drivers of exercise-induced transcriptional programs, then activating them pharmacologically should produce measurable analogs of exercise adaptation. This hypothesis has driven the compound’s development and ongoing research interest.

It is worth noting that SLU-PP-322 exists in a rich research context alongside other compounds targeting metabolic pathways. For example, 5-Amino-1MQ has been studied for its NNMT inhibition and effects on adipocyte metabolism, representing a different but complementary entry point into metabolic research. Similarly, several metabolic compounds are seeing renewed research interest in 2026 as the field matures and diversifies.

5-Amino-1MQ – 50MG for NNMT pathway research →

SLU-PP-322 in the Mitochondrial Research Landscape

Mitochondrial function is a unifying theme across many of the most active research areas in modern biology — from aging and metabolic disease to neurodegeneration and cardiovascular research. SLU-PP-322’s ability to upregulate mitochondrial biogenesis pathways places it firmly within this field of inquiry.

Researchers exploring mitochondrial dysfunction models have interest in compounds that can boost mitochondrial gene expression and improve oxidative capacity. The PPARGC1A-ERR transcriptional axis, which SLU-PP-322 activates, is one of the best-characterized regulatory systems for mitochondrial biogenesis in mammalian cells. This makes the compound a mechanistically precise tool for interrogating this pathway in research systems.

Complementary mitochondrial research tools include MOTS-C, which signals through AMPK and has been described as a mitochondrial-derived peptide in the context of broader mitochondrial research alternatives. Taken together, these compounds offer researchers multiple angles for probing mitochondrial biology.

Laboratory Handling and Research Considerations

For researchers working with SLU-PP-322 in preclinical settings, several practical considerations are relevant:

Compound format: SLU-PP-322 is typically supplied as a lyophilized powder in 5MG quantities, suitable for preparation of working solutions in DMSO or aqueous vehicles depending on the assay system.
Solubility: As a small molecule, SLU-PP-322 has different solubility characteristics compared to peptides. DMSO is commonly used as an initial solvent in cell culture systems, with appropriate dilution into aqueous media.
Storage: Lyophilized compound should be stored according to supplier specifications — typically at -20°C or -80°C in a desiccated environment to maintain stability.
In vitro applications: Cell culture studies using myocytes, cardiomyocytes, or adipocytes have been used to characterize ERR agonist activity and downstream gene expression changes.
In vivo dosing: Rodent studies have employed various administration routes and dosing intervals. Researchers should consult primary literature for protocol context specific to their study design.
Readout selection: Appropriate endpoints for SLU-PP-322 research include qPCR for ERR target genes, mitochondrial content assays (citrate synthase activity, mtDNA:nDNA ratio), seahorse metabolic flux analysis, and exercise performance testing in animal models.

Where These Fit in Your Research Library

SLU-PP-322 fits naturally alongside other metabolic and mitochondrial research compounds. Researchers building a comprehensive metabolic biology toolkit may find these products relevant:

SLU-PP-322 – 5MG (primary ERR agonist research compound) →

MOTS-C – 10MG Nasal Spray (AMPK-mediated metabolic signaling) →

5-Amino-1MQ – 50MG (NNMT inhibition, adipocyte metabolism) →

Explore the full research catalog at SourcePeptides.co →

Final Takeaway

SLU-PP-322 represents one of the most mechanistically interesting compounds in contemporary metabolic research. As a pan-ERR agonist, it provides researchers with a precise tool to activate the transcriptional programs associated with aerobic exercise adaptation — making it valuable for studies of mitochondrial biogenesis, skeletal muscle metabolism, cardiac function, and body composition in preclinical models. Its small-molecule nature distinguishes it from classical peptide research compounds, yet its research applications align closely with the broader goals of metabolic and exercise biology.

For qualified researchers, SLU-PP-322 5MG offers a well-characterized starting point for ERR biology studies. As the field of exercise mimetic research continues to develop, SLU-PP-322 is likely to remain a cornerstone compound for investigating the molecular basis of metabolic adaptation.

Sources & Further Reading

Disclaimer: This article is for informational and research purposes only. The products mentioned are intended for laboratory and research use only and are not for human consumption. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.